ࡱ> `!U {WRzޮx+"/N SP>&# xX xل@P1B8F r bC@P 9CDnPQå JPDEDL8ԝ~5}o꪿{UT^;R%j,T*D|J$Eڒ6rnj}第Ш9I7pTVΐc*F+2,^꽀Ñ.|LJWB'7ʍr#EEEPtV,*%Kqu.#pIA;UZ;߳_8e0H!~µa;mU~Ykw W겈& {">PVBrlmAa[Ƞ ˘{>3̫wg>Ʈqgo1q ˸Jl`g1q,Tqe<D"bfăwv_rێ?$"vbV1GNB>N3/nn1sSGk'YF &_:+/Ӟej( eRLr 0/th/c23rl|`;(jXnR{?l>T׾m- "&fXL Ǚ,C1BW!)=yݥrڙp^qV '8f.څs8.1S+w6bm b''Jحi/t\!g$ɡ]WlE=z^gdӵ:^@z&`h`^u>՛6@Vѿ'pAunp}kGPB̥d\! /ю_cy6z+)PNFQzLNwqѶG _HԫWoУsQ:w].O@qz\@*dѯ}z mSi~;9'TEgqX9vކ//0W1h;-8 ۭR{qܾs9kO"OeS_ixVyR5œFyTϧ瀺sL}f5FPM1, S.W4NT3/C9iɲ$]eGEYr'rΕg9|-j0f۸ǍD*597Z0ua:awi|wḩ r%uOS[ZʵԘbT_a:,FMjMCi&? h8M4#4z2urSkHè * ip/vu؈Kco< p ̂ :um{`Փ^>ܧATc^A9;ں ɘ,a*B `I) ;Q#Ep]ETOM#b}q6G&\*{1(bC[&Qi4y^`<{Nx5.J];}MZ'lȧ0-"&ְ^4)gO=NL>}.Չn4X~gEz>tjKrl9kuq4E׎-}ƱQNpT3-dU$Tr@9} PFjmVw}US#y0vEv/y[+}) ᝲvqR\) q,Ry簎Atq9gۭȤ`jgL}+CSb> X _VD) < T٘}9WGҽrz7ZSA3l@Y׽5=ʱ= {$G3q0gO[1Z:o)@7S m)ZԙVRrve;)vn% :Mg8[oSq#kfknhnxH98KFj\>'^=b ؎|AF!C"ZiY}*#</bqzDwr./ov9v_0OǧS&~+N&ӫxW܈;׽P6j;Z<{b}8V]컦?))Za%)|Ŋ[Y6։Y%OwgBob٨¼E;IJ??\2DnVf(V   91Clip (MS_ClipArt_Gallery.50,Microsoft Clip Galleryd/ 0DTimes New Roman(0(z[ 0 DMonotype Sorts(0(z[ 0  D .  @n?" dd@  @@`` up   !()-.17 ;<=,2${WRzޮx+"/]  AA1? fff3f@889  g4SdSd@z[ 0>ppp@ <4!d!dl 0-g4&d&d@z[ 0p+ pp<4BdBdl 0-Se ʚ;6_v8ʚ;<4ddddl|- 0X9___PPT10 6`___PPT9B/ 0&/? %O:+ &Critical Exposure: 2!I/My Story$ /Details of injury Occupational health follow-up 0 " K0$ Decision to go publicOPersonal considerations Putting a face to the issue Making some sense out of it 6 Needlestick injuries in the US What we knew in 1999: H7 Incidence/frequency estimates Significant underreporting More than 20 BBP (most often hep C) 1000 HCW infections reported/yr Data quality inconsistent Prevention possible 8$t3$YV@()Hepatitis C: An Emerging Silent Epidemic**4M estimated cases in US; 170M worldwide 4X more prevalent than HIV in US pop HCWs 3rd highest occupational risk grp Long latency period with 85% chronic infection; 20-25% develop cirrhosis No current vaccine or prophylaxis Early detection and treatment key &Z ,N  Needlestick injuries in the US What we didn t know:HR;Actual numbers of injuries Actual number of infected workers Injury device specific information Device evaluation information Da$(Needlestick injury costs Lost work/productivity/treatment Occupational health follow-up Studies suggested $1500-$3000 per exposed worker without infection @600,000 injuries/yr = $900M-$1.8B One infected worker: $500,000-$1M over lifetime ${a+Potential costs of injuriesHuman costs Insured costs: medical f/u, HIV prophylaxis, treatment, disability, lost time Uninsured costs: paid wages, OT, replacement workers, clerical/supervisor time Organizational losses @  ^$ " Safer needle technology in 1999#  Available for more than two decades 1000 products on current market 250 FDA approved Poor market penetration (15%) Effectiveness varies (need data) Cost implications/benefit&$$)Cost of technology (1999)Standard blood-drawing device: aver $.07 Safety needle devices: aver $.28 more Up front conversion/incremental costs One study: 300 bed hospital:$17,000 Safety device costs have declined as market penetration increased LDUD Most effective technologiesfActive vs. passive Designs: shield; sheath; retractable Disposal systems Prevent over 80% of injuriesN2A Journey Beyond the PersonalNMassachusetts Nurses Association legislation State advocacy Federal advocacy D,8 2000 Federal Needlestick Safety & Prevention Act :95Amends OSHA BBP standard Requires use of safer devices Frontline nurses and other healthcare workers participate in device selection and evaluation H."Federal legislation components #~Device/injury data collection and logs Written exposure control plan with annual update Ongoing education/training of workers ~K1Where we are today in USIndicators of progress: Market conversion to safety devices Increase in number of OSHA inspections Reduction in number of injuries due to conventional devices Overall decline in number of injuries 6$/3: ; F MOP$ ` f3"V+Nf` 3f3f3f` /.fRP̙` f"ffH` f3f|` MMM>?" dd@,|?" dd@   " @ ` n?" dd@   @@``@n?" dd@  @@``PR    @ ` ` p>>  (v(  ( (  BCPE(F"2@ 8ApP XP@  `@F (  BCETF.@' EuOE[: :Pf@      ` (  0e0e     ?BCE`F2 @ 5% 8c8c     ?1 d0u0@Ty2 NP'p<'p@A)BCD|E?||hD[Drmq>uJ^_! BE@       ` ( S BhC! E<F&@ ! v" bN'\h4ht-2.#; [! ! @    ` (  0e0e     ?BCETF. @ 5% 8c8c     ?1 d0u0@Ty2 NP'p<'p @A)BCD|E?||$ )  _s0|d T A% :$@      `y  (  0e0e     ?BdCHEHF* @ 5% 8c8c     ?1 d0u0@Ty2 NP'p<'p @A)BCD|E?||A @<PdT H"k=_ E;W@     `Y  ( s * P  T Click to edit Master title style! !   ( c $d   TClick to edit Master text styles Second level Third level Fourth level Fifth level!    U  ( c $ ``  @* 2  ( c $ `   B*(2 ( c $< `   B*(2 ( Z2޽h))??"` f"ffH Ribbons   @ ,(   , ,  BCPE(F"2@ 8ApP XP@  `@ ,  0e0e     ?BCE<F& 2@ 5% 8c8c     ?1 d0u0@Ty2 NP'p<'p@A)BCD|E?||FP P  - ffFF@    `F ,  BCETF.@' EuOE[: :Pf@      ` ,  0e0e     ?BCE`F2 @ 5% 8c8c     ?1 d0u0@Ty2 NP'p<'p @A)BCD|E?||hD[Drmq>uJ^_! BE@       ` , S BhC! E<F&@ ! v" bN'\h4ht-2.#; [! ! @    ` ,  0e0e     ?BCETF. @ 5% 8c8c     ?1 d0u0@Ty2 NP'p<'p@A)BCD|E?||$ )  _s0|d T A% :$@      `y  ,  0e0e     ?BdCHEHF* @ 5% 8c8c     ?1 d0u0@Ty2 NP'p<'p @A)BCD|E?||A @<PdT H"k=_ E;W@     `Y  , s *|U p  T Click to edit Master title style! !  , c $,X  `    W#Click to edit Master subtitle style$ $  , c $\ ``  D* 2  , c $M `   F*(2 , c $T `   F*(2 , Z2޽h))? ?"` f"ffH 0 `X` ( K   c $k P  k Z* X   C    k    c $k  @ k RClick to edit Master text styles Second level Third level Fourth level Fifth level!     S   c $k   k \*    s *xk 8PV  k Z*    s *k 8 V k \* N  6޽h? ? ̙3380___PPT10.AUn 8( p$" 8 8 c $ P   h**Karen Daley, MPH, RN  8 c $<    B*  8 s *̍ 8PV   X*Observations of a Needlestick Injured Nurse--  8 s *  8 V  B* H 8 0޽h ? ̙3380___PPT10.A*CV % 0!(     C x:kgֳgֳ ? (0 @<$ 0 k R Karen Daley, PhD (c), MS, MPH, RN Needlestick Injuries Conference Dublin 2006 *SQV  s *AW ? ? p Af  s *@k ( ` <$  0  aCritical Exposure: My Story*0(Z  B2޽h ? f"ffHy___PPT10Y+D=' = @B +  % 0(  x  c $Xek (  k x  c $,fk (@` k H  0޽h ? f"ffHy___PPT10Y+D=' = @B +/ 8 K0 % *"@( $Qg   # llkgֳgֳ ? (  k   # l`mkgֳgֳ ? (0 k B  s *޽h ? 3ffy___PPT10Y+D=' = @B + 8 K0 *"P ( lMMM    # ltkgֳgֳ ? (P`  k   # ltkgֳgֳ ? (`p k B  s *޽h ? 3ffy___PPT10Y+D=' = @B +a  `\(  \l \ C xk (  k l \ C }k ( `@ k H \ 0޽h ? f"ffHy___PPT10Y+D=' = @B +  8 K0 *"$(  AX $ $ # l4kgֳgֳ ? (W  k  $ # lkgֳgֳ ? ( k B $ s *޽h ? 3ffy___PPT10Y+D=' = @B +  K0 $( fff r  S tk (  k r  S k ( k H  0޽h ? ffffy___PPT10Y+D=' = @B +   K0 $(  r  S k (P  k r  S hk (+ k H  0޽h ? ffffy___PPT10Y+D=' = @B +/ 8K0 % *"(( * ( ( # lkgֳgֳ ? (Pp@  k  ( # lkgֳgֳ ? ( 0 k B ( s *޽h ? 3ffy___PPT10Y+D=' = @B + K0 % $(  r  S ܮk (P  k r  S k (+ k H  0޽h ? ffffy___PPT10Y+D=' = @B +/ 8K0 % *",( lg , , # l@kgֳgֳ ? (W  k  , # lkgֳgֳ ? (Y k B , s *޽h ? 3ffy___PPT10Y+D=' = @B +  0(  x  c $pk (P  k x  c $Dk ( k H  0޽h ? f"ffH___PPT10i._0+D=' = @B +  K0 p0( @ px p c $k (@  k x p c $k (0` k H p 0޽h ? 3ffy___PPT10Y+D=' = @B + K0 |<(  |~ | s *k (@  k ~ | s *k ( k H | 0޽h ? 3ffy___PPT10Y+D=' = @B +}  $(  r  S k (P  k r  S xk (Ppp k H  0޽h ? f"ffH___PPT10i._y(+D=' = @B +! 0 P((   ` ^  S       c $  @    H  0޽h ? ̙33 0 D( xqxqXf DX D C      D S cq4v$< [iwG;ιj8[rQoE^ `afWQr}ņ4}v}t~Wwn㵭9S٪d_JQ4^joqٮ\ո6ZBuMsVsq\(~5$Xq`Ԅrѓ=)#'5;s\^eM To((:7Hڷe2TuAh;_N'Q\\ Gas`Ѣ<*my3PhW)5f렰~2dlɧUF Bj˃еL]+}Uáֵ'(J=$KfH8Ҭ,B25|+uO~U |kH:g7z e8u]Tߕ:TǩT㥲bJ=캣Y,kx'y[N$s v3M Z,a虑([j{8!u,-e`ۉj6Ho)ViҭN1nJA^Hj"O𸓠ㆂ$fڠ{GHCݐd12(b{" vnnn=I t,J&QǷWۦK|+u? Lw $y;@>H5#H;cS>3f/9醢"h.&OKVj]2Ws=fΡTs<53ѹ`lHKf @wiKYz G=`iw}ߠ&z]T hC˕c,5f+;;z ?4bĨOtɸ/3Sƣ5OXDkXEӌ4sug%iFGNK d!M+|t\CmxM^szS|JmVE+i(PDhDD#i f<֜4j*[ZSp?ZlZ8í3?WotcxA'BnR{?,Q#`z[P_BOU!SY9޺Gf, ')v؛Z`5Ĺt#|kj.H4phx@4Bhes,p1҄i&Fy 3卶vU`1/&lηIn8xO.No>|Dױn8ZRç}9'W=ϩKzZc3 p؂ z?>Mѳ'?@ABCDEFGHIJKLMNOPQRSTUVWXZ[\]^_`abcdefghijklmnopqrstuvwxyz{|}~Root EntrydO)PicturesCurrent UserSummaryInformation(YUPowerPoint Document(DocumentSummaryInformation8